MX2021012933A - Parche que contiene lidocaina. - Google Patents

Parche que contiene lidocaina.

Info

Publication number
MX2021012933A
MX2021012933A MX2021012933A MX2021012933A MX2021012933A MX 2021012933 A MX2021012933 A MX 2021012933A MX 2021012933 A MX2021012933 A MX 2021012933A MX 2021012933 A MX2021012933 A MX 2021012933A MX 2021012933 A MX2021012933 A MX 2021012933A
Authority
MX
Mexico
Prior art keywords
lidocaine
patch
salt
lactic acid
skin
Prior art date
Application number
MX2021012933A
Other languages
English (en)
Inventor
Masaki Ishibashi
Hidetoshi Hamamoto
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Publication of MX2021012933A publication Critical patent/MX2021012933A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Este parche es bioequivalente a las formulaciones existentes incluso con concentraciones más altas de lidocaína, es altamente seguro y contiene lidocaína o una sal de la misma, ácido láctico y un hidroxiácido con 4-6 carbonos; la tasa de penetración cutánea de la lidocaína cuando se aplica el parche sobre la piel está dentro de un intervalo apropiado, y el efecto terapéutico de la lidocaína se manifiesta de forma persistente durante un largo período de tiempo. El contenido de ácido láctico es de 0.6 a 1.2 mol por 1 mol de lidocaína o una sal de la misma.
MX2021012933A 2019-04-24 2020-04-20 Parche que contiene lidocaina. MX2021012933A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019082678 2019-04-24
JP2019122757 2019-07-01
PCT/JP2020/017075 WO2020218249A1 (ja) 2019-04-24 2020-04-20 リドカイン含有貼付剤

Publications (1)

Publication Number Publication Date
MX2021012933A true MX2021012933A (es) 2021-12-15

Family

ID=72942747

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021012933A MX2021012933A (es) 2019-04-24 2020-04-20 Parche que contiene lidocaina.

Country Status (10)

Country Link
US (1) US20210369636A1 (es)
EP (1) EP3960238A4 (es)
JP (1) JPWO2020218249A1 (es)
KR (1) KR20220004088A (es)
CN (1) CN112512634A (es)
AU (1) AU2020262630A1 (es)
BR (1) BR112021001304A2 (es)
CA (1) CA3136186A1 (es)
MX (1) MX2021012933A (es)
WO (1) WO2020218249A1 (es)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
JPH09110680A (ja) * 1995-10-19 1997-04-28 Yuutoku Yakuhin Kogyo Kk 皮膚炎治療貼付剤
US20040142024A1 (en) * 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
PT1201232E (pt) * 1999-07-27 2007-07-24 Hisamitsu Pharmaceutical Co Emplastros papa uso externo.
CA2703872C (en) 2007-11-11 2015-11-03 Medrx Co., Ltd. Lidocaine tape preparation
US20130224262A1 (en) * 2010-09-03 2013-08-29 Medrx Co., Ltd. Transdermal preparation
CN103608009B (zh) * 2011-06-20 2015-04-29 久光制药株式会社 含有利多卡因的贴膏剂
EP2749279A4 (en) * 2011-08-25 2015-01-21 Nipro Patch Co Ltd AQUEOUS SKIN CARBIDE
DK2823815T3 (en) * 2011-09-27 2018-08-06 Itochu Chemical Frontier Corp NON-DIFFICULT PLASTER
EP3045166B1 (en) * 2013-09-11 2020-12-16 MEDRx Co., Ltd. Novel base composition for tape agent
ES2847936T3 (es) * 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina
US9974754B2 (en) * 2013-12-18 2018-05-22 Maruishi Pharmaceutical Co., Ltd. Hydrous adhesive patch
JP2016003196A (ja) * 2014-06-16 2016-01-12 株式会社カネカ 経皮吸収製剤
KR20190053853A (ko) 2016-09-16 2019-05-20 니찌방 가부시기가이샤 첩부제

Also Published As

Publication number Publication date
EP3960238A4 (en) 2023-01-25
JPWO2020218249A1 (es) 2020-10-29
KR20220004088A (ko) 2022-01-11
CA3136186A1 (en) 2020-10-29
EP3960238A1 (en) 2022-03-02
WO2020218249A1 (ja) 2020-10-29
US20210369636A1 (en) 2021-12-02
CN112512634A (zh) 2021-03-16
AU2020262630A1 (en) 2021-12-16
BR112021001304A2 (pt) 2021-11-16

Similar Documents

Publication Publication Date Title
MX2023008453A (es) Metodos de tratamiento para el abuso de sustancias.
MX2019013574A (es) Amidas de piridona deuteradas y sus profarmacos como moduladores de los canales de sodio.
MY181540A (en) Transdermal composition containing donepezil as active ingredient
PH12020551597A1 (en) Treatment of hidradenitis suppurativa using jak inhibitors
MX2022007083A (es) Composicion de espuma oral.
MX2019006207A (es) Forma polimorfica de sepiapterina.
SG11201906787UA (en) Injectable composition for preventing hair loss or stimulating hair growth
NZ628092A (en) Transdermal delivery system
PH12020550452A1 (en) New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild)
MX2021000363A (es) Uso de estimuladores de la guanilato ciclasa soluble (sgc) para el tratamiento de trastornos mitocondriales.
GEP20196969B (en) New therapeutical composition containing apomorphine as active ingredient
BR112013028786A2 (pt) método e composição de tratamento de sementes
AU2016216741A1 (en) Compositions and methods of use of an inappetance-controlling compound
NZ599265A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX2020002889A (es) Un esteroide c21-n-pirazolilo 19-nor c3,3-disustituido, y métodos de uso del mismo.
AU2017312811A8 (en) Liquid naloxone spray
AU2017261160A1 (en) Implant surfaces for pain control
WO2023081830A3 (en) Compositions and treatments with nirogacestat
MX2019008115A (es) Formulaciones topicas de detomidina.
MX2021012933A (es) Parche que contiene lidocaina.
EP3590338A3 (en) Medical treatments based on anamorelin
GEP20063822B (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
NZ594154A (en) Transdermal administration of buprenorphine for preoperative treatment of post operative pain
WO2023004282A3 (en) Il12 receptor agonists and methods of use thereof
AU2020370161A8 (en) Use of pine resin for treating and preventing muscle soreness and foot & joint pain